Pre-mRNA splice switching or regulatory oligonucleotides containing bicyclic scaffold moieties with improved characteristics for the treatment of genetic disorders

摘要

The present invention provides antisense splice switching oligonucleotides with improved features that enhance clinical applicability to treat, ameliorate, prevent and / or delay neuromuscular disorders such as DMD. [Selection figure] None